SMTL ID : 5mz3.1

P38 ALPHA MUTANT C162S IN COMPLEX WITH CMPD2 [N-(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-(trifluoromethyl)benzamide]

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

monomer

Ligands

1 x 8EN: ~{N}-[3-(2-acetamidoimidazo[1,2-a]pyridin-6-yl)-4-methyl-phenyl]-3-(trifluoromethyl)benzamide(Non-covalent)

8EN.1: 17 residues within 4Å: Chain A: V.47, A.60, K.62, E.80, L.83, L.84, V.92, I.93, L.113, T.115, L.117, M.118, H.157, I.175, L.176, D.177, F.178 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:V.47, A:A.60, A:K.62, A:L.83, A:L.84, A:I.93, A:L.113, A:T.115, A:L.117, A:D.177, A:F.178 Hydrogen bonds: A:K.62, A:E.80, A:M.118, A:D.177 Water bridges: A:V.39 pi-Stacking: A:F.178, A:F.178 pi-Cation interactions: A:K.62

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Smith, A. et al., Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitors. Bioorg. Med. Chem. Lett. (2017)

Release Date

2017-11-15

Peptides

Mitogen-activated protein kinase 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 14